Are small residual stone fragments really insignificant in children?

Nida Dincel1, Berkan Resorlu, Ali Unsal

  • 1Department of Pediatric Nephrology, Ege University, Faculty of Medicine, Izmir, Turkey.

Insights

Pediatric kidney stones less than 4mm, termed clinically insignificant residual fragments (CIRFs), often become symptomatic or regrow. These fragments require careful monitoring as spontaneous passage is uncommon.

Area of Science:

  • Pediatric Urology
  • Nephrolithiasis Management
  • Minimally Invasive Surgery

Background:

  • Residual stone fragments after pediatric urolithiasis procedures are common.
  • The clinical significance of small (less than 4mm) asymptomatic residual fragments, termed clinically insignificant residual fragments (CIRFs), remains debated.
  • Current management strategies often involve observation, but the natural history of CIRFs in children is not well-defined.

Purpose of the Study:

  • To evaluate the significance of asymptomatic residual stone fragments (<4mm) in children following shock wave lithotripsy (SWL), percutaneous nephrolithotomy (PNL), and retrograde intrarenal surgery (RIRS).
  • To determine the rates of spontaneous passage, re-growth, and symptomatic events associated with these residual fragments.
  • To assess the appropriateness of the term "clinically insignificant residual fragments" (CIRFs) in the pediatric population.

Main Methods:

  • A prospective study followed 85 children with residual fragments (<4mm) for a median of 22 months (range 6-50 months).
  • Outcomes assessed included spontaneous fragment passage, fragment re-growth, and stone-related events (e.g., emergency visits, hospitalizations, interventions).
  • Statistical analysis was performed to evaluate factors influencing outcomes, including stone location and number.

Main Results:

  • 25.8% of children spontaneously passed residual fragments, with higher rates for renal pelvis stones (57.1%) versus lower pole stones (16.1%).
  • 40% of patients experienced symptomatic episodes (renal colic, UTI, hematuria), and 21.2% had fragment re-growth.
  • 29.4% required secondary interventions, and 23.5% needed medical management for complications, suggesting CIRFs are not always insignificant.

Conclusions:

  • The term "clinically insignificant residual fragments" (CIRFs) may not be appropriate for postoperative residual fragments in children.
  • A significant proportion of children with CIRFs experience symptoms, fragment re-growth, or require further interventions.
  • Close monitoring and potentially proactive management of residual fragments in pediatric stone disease are warranted.
Abstract

Related Concept Videos

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
Urinary Tract Calculi VI: Surgical Management01:25

Urinary Tract Calculi VI: Surgical Management

Procedures for Kidney StonesMedical intervention is necessary when kidney stones or renal calculi are too large to pass spontaneously (typically greater than 5 millimeters) when stones are accompanied by symptomatic infection (such as fever or pyelonephritis), when they impair kidney function, or when they cause persistent symptoms like severe pain, nausea, or urinary retention. Additionally, patients with only one kidney or those who cannot be treated with medical management also require...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
Urinary Tract Calculi III: Medical Management01:30

Urinary Tract Calculi III: Medical Management

The diagnosis of renal calculi involves several imaging techniques, including non-contrast CT scans and ultrasound. These methods help visualize kidney stones, assess their size and location, and detect possible obstructions. Additionally, Measuring urine pH is useful for diagnosing specific stone types, such as struvite (alkaline pH) and uric acid stones (acidic pH). Cystine stones are primarily linked to cystinuria, a genetic condition. A urinalysis helps detect blood in the urine (hematuria)...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...